SEC Form 4 · accession 0001705477-26-000001
Edgewise Therapeutics, Inc. · EWTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Michael Nofi
Officer — Chief Financial Officer
Period of report
Aug 12, 2026
Accepted (ET)
Aug 14, 2026 · 4:54 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001710072
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | $0.00 | Aug 12, 2026 | A | 24,375 | A | — | Aug 12, 2036 | Common Stock | 24,375 | 24,375 | D |
| Stock Option (Right to Buy)F2 | $0.00 | Aug 12, 2026 | A | 48,750 | A | — | Aug 12, 2036 | Common Stock | 48,750 | 48,750 | D |
Explanation of responses
- F1Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2027.
- F21/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date.